Dubuisson, N.; Versele, R.; Davis-López de Carrizosa, M.A.; Selvais, C.M.; Noel, L.; Planchon, C.; Van den Bergh, P.Y.K.; Brichard, S.M.; Abou-Samra, M.
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle. Cells 2023, 12, 2101.
https://doi.org/10.3390/cells12162101
AMA Style
Dubuisson N, Versele R, Davis-López de Carrizosa MA, Selvais CM, Noel L, Planchon C, Van den Bergh PYK, Brichard SM, Abou-Samra M.
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle. Cells. 2023; 12(16):2101.
https://doi.org/10.3390/cells12162101
Chicago/Turabian Style
Dubuisson, Nicolas, Romain Versele, Maria A. Davis-López de Carrizosa, Camille M. Selvais, Laurence Noel, Chloé Planchon, Peter Y. K. Van den Bergh, Sonia M. Brichard, and Michel Abou-Samra.
2023. "The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle" Cells 12, no. 16: 2101.
https://doi.org/10.3390/cells12162101
APA Style
Dubuisson, N., Versele, R., Davis-López de Carrizosa, M. A., Selvais, C. M., Noel, L., Planchon, C., Van den Bergh, P. Y. K., Brichard, S. M., & Abou-Samra, M.
(2023). The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle. Cells, 12(16), 2101.
https://doi.org/10.3390/cells12162101
